Is Kalvista Pharmaceuticals Kalv Stock Rebounding Price At 19.98 Up 3.04 20260328 Modella Emerges as Controlling Force in HighStakes Revival of Former WH Smith Chain Datacentre Energy Demand Surges to 6 of UK and US Electricity Supply AI Growth Driving Global Investment Toward 1 Trillion Iran Conflict and US Trade Policies Persist as Key Concerns for Bank of Canada Rate Decisions BYD in Talks to Acquire Idle European Plants Eyes Maserati Brand Microsoft Appoints Jenny LayFlurrie to Lead Responsible AI Development Amid Speed vs Safety Tension Reid Hoffman Raises 246 Million for AIPowered CancerResearch Venture Manas AI Kevin Warsh Takes Over as Fed Chair Pledges ReformOriented Agenda at White House Ceremony Lenovo Shares Surge Nearly 20 on Record Earnings and AI Revenue Growth Why Most US Manufacturers Still Arent Using AI and Automation Analysis Morgan Stanley Lowers Equinor Price Target Following FirstQuarter Results BJs Wholesale Club Q1 2026 Earnings EPS Edges Past Estimates as Stock Slips Slightly REVB Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Awaits Clinical Milestones BHC Q1 2026 Earnings EPS Surges Past Expectations Despite Revenue Uncertainty Newmont Q1 2026 Earnings EPS Beats Estimates by Wide Margin as Gold Prices Boost Results EQT Q1 2026 Earnings Strong EPS Beat as Natural Gas Fundamentals Tighten COVIDEra IRS Penalty Refunds Window Closing Fast for Millions of Taxpayers WMS Q1 2026 Earnings Strong EPS Surprise Despite Stock Decline